Literature DB >> 30460573

Residual high intrapulmonary shunt fraction limits exercise capacity in patients treated with balloon pulmonary angioplasty.

Makoto Takei1, Takashi Kawakami2, Masaharu Kataoka1, Ichiro Kuwahira3, Keiichi Fukuda1.   

Abstract

Balloon pulmonary angioplasty (BPA) has emerged as a new treatment strategy for patients with chronic thromboembolic pulmonary hypertension (CTEPH). Improvements in hemodynamic parameters after BPA have been reported, but some patients continue to suffer from reduced exercise tolerance even after the normalization of hemodynamic parameters following BPA. As the amelioration of hemodynamic parameters is reportedly achieved via BPA, we hypothesized that the limiting factors for exercise tolerance in these patients are related to respiratory function. Therefore, we investigated the associations between respiratory function and exercise tolerance, and the mechanisms underlying respiratory dysfunction in patients after BPA. We analyzed 62 patients with CTEPH who underwent 1-year follow-up after BPA. Predictors for reduced exercise tolerance after BPA determined with six-minute walk test were sought from pulmonary hemodynamic and respiratory parameters using logistic regression analysis. After multivariate adjustments, high mean right atrium pressure (mRAP) and high alveolar-arterial oxygen gradient (A-aDO2) were significant predictors for reduced exercise tolerance. Next, we analyzed factors associated with high A-aDO2. Among the pathophysiological causes of high A-aDO2, including ventilation, diffusing capacity, and low ventilation-perfusion ratio, only low ventilation-perfusion ratio caused by high intrapulmonary shunt fraction was associated with high A-aDO2. Impaired oxygenation due to residual high intrapulmonary shunt fraction was associated with reduced exercise tolerance in patients with CTEPH, after receiving BPA.

Entities:  

Keywords:  Balloon pulmonary angioplasty; Chronic thromboembolic pulmonary hypertension; Exercise tolerance; Respiratory function

Mesh:

Substances:

Year:  2018        PMID: 30460573     DOI: 10.1007/s00380-018-1306-2

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  14 in total

1.  Retrograde Approach in Balloon Pulmonary Angioplasty: Useful Novel Strategy for Chronic Total Occlusion Lesions in Pulmonary Arteries.

Authors:  Takashi Kawakami; Masaharu Kataoka; Takahide Arai; Ryo Yanagisawa; Yuichiro Maekawa; Keiichi Fukuda
Journal:  JACC Cardiovasc Interv       Date:  2015-12-23       Impact factor: 11.195

Review 2.  Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.

Authors:  Luis Puente-Maestu; Paolo Palange; Richard Casaburi; Pierantonio Laveneziana; François Maltais; J Alberto Neder; Denis E O'Donnell; Paolo Onorati; Janos Porszasz; Roberto Rabinovich; Harry B Rossiter; Sally Singh; Thierry Troosters; Susan Ward
Journal:  Eur Respir J       Date:  2016-01-21       Impact factor: 16.671

Review 3.  Chronic thromboembolic pulmonary hypertension.

Authors:  Gregory Piazza; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2011-01-27       Impact factor: 91.245

4.  Long-Term Outcomes After Percutaneous Transluminal Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Takumi Inami; Masaharu Kataoka; Ryoji Yanagisawa; Haruhisa Ishiguro; Nobuhiko Shimura; Keiichi Fukuda; Hideaki Yoshino; Toru Satoh
Journal:  Circulation       Date:  2016-12-13       Impact factor: 29.690

5.  Standardization of Spirometry, 1994 Update. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

6.  Significance of echocardiographic assessment for right ventricular function after balloon pulmonary angioplasty in patients with chronic thromboembolic induced pulmonary hypertension.

Authors:  Toshimitsu Tsugu; Mitsushige Murata; Takashi Kawakami; Risako Yasuda; Hanako Tokuda; Yugo Minakata; Yuichi Tamura; Masaharu Kataoka; Kentaro Hayashida; Hikaru Tsuruta; Yuichiro Maekawa; Soushin Inoue; Keiichi Fukuda
Journal:  Am J Cardiol       Date:  2014-10-31       Impact factor: 2.778

7.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

8.  Safety and efficacy of percutaneous transluminal pulmonary angioplasty in elderly patients.

Authors:  Ryoji Yanagisawa; Masaharu Kataoka; Takumi Inami; Nobuhiko Shimura; Haruhisa Ishiguro; Keiichi Fukuda; Hideaki Yoshino; Toru Satoh
Journal:  Int J Cardiol       Date:  2014-05-16       Impact factor: 4.164

9.  Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension.

Authors:  Masaharu Kataoka; Takumi Inami; Kentaro Hayashida; Nobuhiko Shimura; Haruhisa Ishiguro; Takayuki Abe; Yuichi Tamura; Motomi Ando; Keiichi Fukuda; Hideaki Yoshino; Toru Satoh
Journal:  Circ Cardiovasc Interv       Date:  2012-11-06       Impact factor: 6.546

10.  Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension.

Authors:  Hiroki Mizoguchi; Aiko Ogawa; Mitsuru Munemasa; Hiroshi Mikouchi; Hiroshi Ito; Hiromi Matsubara
Journal:  Circ Cardiovasc Interv       Date:  2012-11-27       Impact factor: 6.546

View more
  2 in total

1.  Exercise right heart catheterization before and after balloon pulmonary angioplasty in inoperable patients with chronic thromboembolic pulmonary hypertension.

Authors:  Christoph B Wiedenroth Md; Andreas J Rieth Md; Steffen Kriechbaum Md; H-Ardeschir Ghofrani Md; Andreas Breithecker Md; Moritz Haas Md; Fritz Roller Md; Manuel J Richter Md; Mareike Lankeit; Lisa Mielzarek; Andreas Rolf Md; Christian W Hamm Md; Eckhard Mayer Md; Stefan Guth Md; Christoph Liebetrau Md
Journal:  Pulm Circ       Date:  2020-08-18       Impact factor: 3.017

2.  Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment.

Authors:  Asako Yanagisawa; Akira Naito; Takayuki Jujo-Sanada; Nobuhiro Tanabe; Keiichi Ishida; Goro Matsumiya; Rika Suda; Hajime Kasai; Ayumi Sekine; Toshihiko Sugiura; Ayako Shigeta; Seiichiro Sakao; Koichiro Tatsumi; Takuji Suzuki
Journal:  BMC Pulm Med       Date:  2021-12-09       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.